Results 161 to 170 of about 31,188 (302)

Chinook winds and migraine attack onset in children and adolescents: A prospective longitudinal clinical cohort study

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 96-107, January 2026.
ABSTRACT Objective To explore the relationship between migraine attack onset in children and adolescents and Chinooks, which are dry and warm westerly winds that generally occur in the winter and bring about abrupt weather changes to the east of the Rocky Mountains in Southern Alberta, Canada. Methods This was a prospective longitudinal clinical cohort
Rylan Heart Villaruz   +6 more
wiley   +1 more source

Do patients with migraine and obesity receive different treatments? Insights from real‐world data

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 88-95, January 2026.
Abstract Background Patients with obesity often experience stigma in healthcare, which may lead to underdiagnosis or undertreatment. In the context of pain management, and migraine specifically, patients with obesity are more likely to receive both opioid and non‐opioid analgesics.
Keshet Pardo   +3 more
wiley   +1 more source

Migraine headache is present in the aura phase – a prospective study [PDF]

open access: gold, 2013
Jakob Møller Hansen   +7 more
openalex   +1 more source

False nonresponders to anti‐calcitonin gene‐related peptide monoclonal antibodies: A real‐world analysis beyond migraine frequency reduction

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 172-182, January 2026.
Abstract Objectives/Background Reimbursement criteria for anti‐calcitonin gene‐related peptide (CGRP) monoclonal antibodies (MAbs) typically rely on predefined reductions in monthly migraine days (MMD). However, this approach may fail to capture the full spectrum of treatment benefits, potentially leading to premature discontinuation in patients ...
Albert Muñoz‐Vendrell   +7 more
wiley   +1 more source

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2). [PDF]

open access: yes, 2019
BACKGROUND: Patients with high-frequency episodic migraine (HFEM) have a greater disease burden than those with low-frequency episodic migraine (LFEM).
Day, Katie A.   +4 more
core   +1 more source

The management of chronic pain in pregnancy

open access: yesThe Obstetrician &Gynaecologist, Volume 28, Issue 1, Page 16-29, January 2026.
Key content Chronic pain is of increasing relevance in clinical practice and may affect a significant proportion of pregnant women. Effective management demands a balance between adequate pain control and minimisation of risks to the fetus. Chronic pain medicines have varying safety profiles with regard to teratogenicity, pregnancy outcomes and ...
Lawrence Hutchinson   +5 more
wiley   +1 more source

Concurrent Brain Structural and Functional Alterations in Patients with Migraine without Aura: An fMRI Study

open access: gold, 2020
Zhengjie Li   +8 more
openalex   +1 more source

Response to the Letter to the Editor: “Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of CGRP‐Related Therapies in Moyamoya Angiopathy”

open access: yes
European Journal of Neurology, Volume 33, Issue 1, January 2026.
Nicola Rifino   +8 more
wiley   +1 more source

Vivid Dreams and Nightmares as an Adverse Effect of Beta‐Blockers in the Treatment of Episodic Migraine

open access: yesCase Reports in Neurological Medicine, Volume 2026, Issue 1, 2026.
Beta‐adrenergic blockers are effective in migraine prevention but can induce neuropsychiatric side effects, including vivid dreams and nightmares. Their lipophilicity allows penetration of the central nervous system, where β1‐adrenergic blockade may disrupt REM sleep, alter noradrenergic activity, and suppress melatonin secretion, contributing to ...
Carlos R. Silva-Rosas   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy